Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|January 25, 2017
Human Dendritic Cell-Derived Induced Pluripotent Stem Cell Lines Are Not ImmunogenicArvind Chhabra, I-Ping Chen, Deepika BatraExpert Opinion on Therapeutic Targets|December 10, 2016
Activation induced cell death (AICD) of human melanoma antigen-specific TCR engineered CD8 T cells involves JNK, Bim and p53Arvind Chhabra, Bijay Mukherji, Deepika BatraTuberculosis (Edinburgh, Scotland)|May 16, 2019
Vitamin D modulates human macrophage response to Mycobacterium tuberculosis DNAJorge L Cervantes, Esther Oak, John Garcia, et al.Thescientificworldjournal|January 11, 2011
TCR-engineered, customized, antitumor T cells for cancer immunotherapy: advantages and limitationsArvind ChhabraFrontiers in Immunology|September 5, 2017
Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement TherapyArvind ChhabraEndocrine, Metabolic & Immune Disorders Drug Targets|October 8, 2009
MHC class I TCR engineered anti-tumor CD4 T cells: implications for cancer immunotherapyArvind ChhabraVaccine|May 11, 2010
Mitochondria-centric activation induced cell death of cytolytic T lymphocytes and its implications for cancer immunotherapyArvind ChhabraStem Cell Reviews and Reports|September 18, 2017
Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent AdvancesArvind ChhabraHuman Immunology|June 21, 2016
Suppression of inducible CD4 regulatory cells by MHC class I-restricted human tumor epitope specific TCR engineered multifunctional CD4 T cellsArvind Chhabra, Bijay MukherjiJournal of Immunology (Baltimore, Md. : 1950)|August 13, 2013
Death receptor-independent activation-induced cell death in human melanoma antigen-specific MHC class I-restricted TCR-engineered CD4 T cellsArvind Chhabra, Bijay MukherjiPageof 8